Divalproex sodium extended-release for the prophylaxis of migraine headache

By Freitag Fred G  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1573-1578

Informa Healthcare

Access to resources Recommend Favorite

Bioavailability of a Divalproex Extended-Release Formulation versus the Conventional Divalproex Formulation in Adult Patients Receiving Enzyme-Inducing Antiepileptic Drugs

By Sommerville K.W.  

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 661-670

Adis International

Access to resources Recommend Favorite

Development of Extended Release Divalproex Sodium Tablets Containing Hypdrophobic and Hydrophilic Matrix

By  

Current Drug Delivery, Vol. 6, Iss. 3, 2009-07 ,pp. : 291-296

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Half-Life is a Meaningful Descriptor of Steady-State Pharmacokinetics of an Extended-Release Formulation of a Rapidly Cleared Drug: As Shown by Once-Daily Divalproex-ER

By Dutta Sandeep   Reed Ronald C.  

Clinical Drug Investigation, Vol. 26, Iss. 12, 2006-01 ,pp. : 681-690

Adis International

Access to resources Recommend Favorite

Oxcarbazepine versus Divalproex Sodium for the Continuing Treatment of Mania

By Reinstein M.J.   Sonnenberg J.G.   Hedberg T.G.   Jones L.E.   Reyngold P.  

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 671-677

Adis International

Access to resources Recommend Favorite